Adma Biologics (ADMA) Research & Development (2016 - 2025)
Historic Research & Development for Adma Biologics (ADMA) over the last 13 years, with Q3 2025 value amounting to $1.5 million.
- Adma Biologics' Research & Development rose 27087.38% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 10214.13%. This contributed to the annual value of $1.8 million for FY2024, which is 4506.06% down from last year.
- Latest data reveals that Adma Biologics reported Research & Development of $1.5 million as of Q3 2025, which was up 27087.38% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Adma Biologics' Research & Development registered a high of $1.5 million during Q3 2025, and its lowest value of $391000.0 during Q4 2024.
- Over the past 5 years, Adma Biologics' median Research & Development value was $826000.0 (recorded in 2025), while the average stood at $829368.4.
- As far as peak fluctuations go, Adma Biologics' Research & Development plummeted by 6008.55% in 2024, and later skyrocketed by 27087.38% in 2025.
- Quarter analysis of 5 years shows Adma Biologics' Research & Development stood at $728928.0 in 2021, then skyrocketed by 47.42% to $1.1 million in 2022, then plummeted by 58.49% to $446000.0 in 2023, then fell by 12.33% to $391000.0 in 2024, then surged by 290.79% to $1.5 million in 2025.
- Its last three reported values are $1.5 million in Q3 2025, $1.0 million for Q2 2025, and $826000.0 during Q1 2025.